Extensively drug-resistant tuberculosis Current Affairs, GK & News
Sree Chitra Tirunal Institute develops an anti cancer anti-inflamatory drug conjugated to human serum Albumin
The Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) has recently developed an anti cancer anti-inflamatory drug conjugated to the human serum Albumin. It is an intravenous delivery system, enabling 100 fold increase in drug bio-availability and is a mix of human serum albumin and a plant based drug. This combination is the ..
Topics: Albumin • Branches of biology • Extensively drug-resistant tuberculosis • Infectious diseases • Medical specialties • Polymerase chain reaction • Serum • Totally drug-resistant tuberculosis • Tuberculosis • Tuberculosis in India
In March, 2018, the Union Health Ministry has released the National Anti-TB Drug Resistance Survey report. The findings of the report include: India which is home to 2.8 million TB patients, the largest in the world of which over a quarter of patients in India could be resistant to one or more drugs that can ..
Topics: Antibiotic-resistant bacteria • Clinical medicine • Extensively drug-resistant tuberculosis • Health • Medicine • Multi-drug-resistant tuberculosis • Multiple drug resistance • Totally drug-resistant tuberculosis • Tuberculosis • Tuberculosis in India • XDR
According to World Health Organisation (WHO)’s Global TB Report 2017, India topped the list of seven countries, accounting for 64% of the 10.4 million new tuberculosis (TB) cases worldwide in 2016. Indonesia has acquired 2nd position, followed by China, Philippines, Pakistan, Nigeria and South Africa. As per new TB report, an estimated 1.7 million people ..